COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve

29/04/2024 - 21:30

COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the award of a contract valued at EUR 65 million to supply its MVA-BN ® smallpox vaccine to the strategic reserve within the European [...]

Flore Customized Probiotics Plays a Role in Netflix Gut Health Documentary

29/04/2024 - 19:33

The Informative Film Follows the “Gut Journeys” of Four People to Educate Consumers About the Gut Microbiome and Its Impact on Overall Health and Well-being SAN DIEGO, April 29, 2024 (GLOBE NEWSWIRE) -- We don’t expect [...]

Ceapro Inc. Reports 2023 Financial Results and Operational Highlights

29/04/2024 - 15:00

– 2023 marked by Ceapro’s achievement of key milestones and progress toward its next phase of growth – R&D activities focused on advancement of avenanthramide Phase 1-2a clinical study and the processing of yeast [...]

Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals

29/04/2024 - 15:00

THE WOODLANDS, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Lonnel Coats has provided notice of his retirement as chief executive officer and as a member of [...]

Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase

29/04/2024 - 15:00

ISELIN, N.J., April 29, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve the first approval for an ophthalmic formulation of bevacizumab for the [...]

AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer

29/04/2024 - 14:55

Next safety cohort to begin escalated dosing soon OCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has taken an essential step [...]

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET

29/04/2024 - 14:45

HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2024 before the market opens on May 7, 2024, and will hold [...]

SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study

29/04/2024 - 14:45

– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3 REGAL Trial Patients Treatment and Follow-Up Without Any Modifications – – IDMC Will [...]

GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity

29/04/2024 - 14:45

LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the [...]

Cerevance to Participate at Upcoming Investor Conferences

29/04/2024 - 14:30

BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system diseases, today announced that company management will participate in the [...]

Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™

29/04/2024 - 14:30

The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular procedures BRAINTREE, Mass., April 29, 2024 (GLOBE [...]

Verspeeten Family Cancer Centre Unveiling Marks a Historic Milestone in Cancer Research and Treatment

29/04/2024 - 14:30

LONDON, Ontario, April 29, 2024 (GLOBE NEWSWIRE) -- London Health Sciences Foundation (LHSF) is proud to announce the unveiling of the new Verspeeten Family Cancer Centre at London Health Sciences Centre (LHSC). This [...]

Smart For Life to Attend National Pet Food Forum on April 29 to May 2

29/04/2024 - 14:30

Company to Explore Strategic Partnerships and Identify Potential Acqusitions MIAMI, April 29, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the [...]

Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease

29/04/2024 - 16:10

Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild AD Improvement in cognition measured by ADAS-Cog 11 at three months is 3.3 points as [...]

TFF Pharmaceuticals Makes Available Phase 2 Data from Tacrolimus Inhalation Powder (TFF TAC) for the Prevention of Lung Transplant Rejection Presented at the Recent ISHLT Annual Meeting

29/04/2024 - 16:00

Data Now Available on Company Website Following 8-K Filing Data Demonstrate that Treatment with TFF TAC Prevents Lung Transplant Rejection at Only One-sixth of the Dose of Oral Tacrolimus and at Two-thirds of the Oral [...]

Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma

29/04/2024 - 15:39

European Orphan Drug Designation (“ODD”) qualifies NXC-201 for: 10 years of market exclusivity once authorized in the EU Access to the EU centralized authorization procedure Reduced fees for: EU protocol assistance, [...]

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

29/04/2024 - 15:15

FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused [...]

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

29/04/2024 - 15:03

COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration (FDA) for a Biologics License [...]

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

29/04/2024 - 15:00

FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the first quarter 2024 after [...]